US Patent 10568317 Reduction of erythrocyte sedimentation rate

Patent 10568317 was granted and assigned to Biomatrica on February, 2020 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Biomatrica

Current Assignee

Biomatrica

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

10568317

Date of Patent

February 25, 2020

Patent Application Number

15780590

Date Filed

December 6, 2016

Patent Primary Examiner

‌

Heidi Reese

Patent abstract

The present invention relates to reduction of erythrocyte sedimentation rate in a blood sample. In particular, formulations, compositions, articles of manufacture, kits and methods for reduced erythrocyte sedimentation rate in a blood sample are provided.